反应详情

Using 4-(4-{2-[bis-(4-methoxy-benzyl)-amino]-pyrimidin-5-yl}-2-morpholin-4-yl-5,6-dihydro-pyrrolo[2,3-d]pyrimidin-7-yl)-benzoic acid (38 mg) obtained in Step A in Example 1-D-19 and 2-(2-aminoethoxy)ethanol (6 μl) instead of 3-(aminomethyl)pyridine, in the same manner as Step B in Example 1-D-19, 4-(4-{2-[bis-(4-methoxy-benzyl)-amino]-pyrimidin-5-yl}-2-morpholin-4-yl-5,6-dihydro-pyrrolo[2,3-d]pyrimidin-7-yl)-N-[2-(2-hydroxy-ethoxy)-ethyl]-benzamide was obtained, and further PMB group was removed according to the above Deprotection method 3, to obtain the desired compound (D-179) as a colorless powder (3 mg, 10%).

1. customfurther PMB group was removed